Viridian Therapeutics has risen more than 5% past an 18.27 entry in a first-stage consolidation, meaning it's now out of a ...
Tonix Pharmaceuticals TNXP saw a positive improvement to its Relative Strength (RS) Rating on Thursday, rising from 65 to 78.